Eli Lilly
Lilly Unveils TuneLab, $1B AI Platform for Biotech Drug Discovery
Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines New offering expands Lilly Catalyze360’s support for early-stage drug development September 11, 2025: Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that provides biotech companies access to drug discovery models […]
Mohamed Mosaed ·
